210 related articles for article (PubMed ID: 23783043)
21. [An introduction to competing risks analysis].
Pintilie M
Rev Esp Cardiol; 2011 Jul; 64(7):599-605. PubMed ID: 21621892
[TBL] [Abstract][Full Text] [Related]
22. Impact of biochemical recurrence in prostate cancer among US veterans.
Uchio EM; Aslan M; Wells CK; Calderone J; Concato J
Arch Intern Med; 2010 Aug; 170(15):1390-5. PubMed ID: 20696967
[TBL] [Abstract][Full Text] [Related]
23. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM; Dickman PW
Cancer Causes Control; 2013 Mar; 24(3):505-15. PubMed ID: 23296456
[TBL] [Abstract][Full Text] [Related]
24. Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account.
Evans DW; Ryckelynck JP; Fabre E; Verger C
Nephrol Dial Transplant; 2010 Jul; 25(7):2315-22. PubMed ID: 20103502
[TBL] [Abstract][Full Text] [Related]
25. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
[TBL] [Abstract][Full Text] [Related]
26. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy.
Boorjian SA; Tollefson MK; Rangel LJ; Bergstralh EJ; Karnes RJ
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):56-62. PubMed ID: 21808286
[TBL] [Abstract][Full Text] [Related]
28. Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.
D'Amico AV; Braccioforte MH; Moran BJ; Chen MH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1329-37. PubMed ID: 19879061
[TBL] [Abstract][Full Text] [Related]
29. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
30. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
de Vries SH; Postma R; Raaijmakers R; Roemeling S; Otto S; de Koning HJ; Schröder FH
Eur Urol; 2007 Feb; 51(2):366-74; discussion 374. PubMed ID: 16930812
[TBL] [Abstract][Full Text] [Related]
31. Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.
Nanda A; Chen MH; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin M; Ross R; D'Amico AV
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):147-52. PubMed ID: 19744800
[TBL] [Abstract][Full Text] [Related]
32. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis.
Lacny S; Wilson T; Clement F; Roberts DJ; Faris P; Ghali WA; Marshall DA
J Clin Epidemiol; 2018 Jan; 93():25-35. PubMed ID: 29045808
[TBL] [Abstract][Full Text] [Related]
33. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Shilkrut M; Merrick GS; McLaughlin PW; Stenmark MH; Abu-Isa E; Vance SM; Sandler HM; Feng FY; Hamstra DA
Cancer; 2013 Feb; 119(3):681-90. PubMed ID: 22893254
[TBL] [Abstract][Full Text] [Related]
34. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
35. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
Orsted DD; Nordestgaard BG; Jensen GB; Schnohr P; Bojesen SE
Eur Urol; 2012 May; 61(5):865-74. PubMed ID: 22104593
[TBL] [Abstract][Full Text] [Related]
37. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
Otto SJ; Schröder FH; de Koning HJ
J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer: net survival and cause-specific survival rates after multiple imputation.
Morisot A; Bessaoud F; Landais P; Rébillard X; Trétarre B; Daurès JP
BMC Med Res Methodol; 2015 Jul; 15():54. PubMed ID: 26216355
[TBL] [Abstract][Full Text] [Related]
39. Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?
Froehner M; Koch R; Litz RJ; Hakenberg OW; Wirth MP
BJU Int; 2012 Jul; 110(2):206-10. PubMed ID: 22044591
[TBL] [Abstract][Full Text] [Related]
40. ["That flesh, pink and perishable": analysis of disease-free survival analysis in breast cancer in Gipuzkoa (Spain) in the presence of competing risks].
Martínez-Camblor P; Larrañaga N; Sarasqueta C; Mitxelena MJ; Basterretxea M
Gac Sanit; 2009; 23(6):554-7. PubMed ID: 19748708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
